138%
net-revenue retention, 2023 cohort, 18 months in.
Not a feature. Not an experiment.
A repeatable motion.
Chain Owner

Why Pharmacy

21,000 independent pharmacy chains in the U.S.

$0 of venture investment in vertical SaaS for this segment before 2022

Median owner age 54 — succession crisis accelerates software adoption

Regulatory complexity creates 18-month data moat once integrated

Zero churn once billing automation module is live

Land-and-Expand Motion

1
POS & Inventory
$420/mo • 90% attach rate
2
Insurance Billing Automation
$680/mo • 67% attach at 6 months
3
Patient Loyalty Engine
$310/mo • 41% attach at 12 months
Average Contracted ARR per Customer at Full Attach
$17,040

Cohort Performance

ARR at Month 18 and Net Revenue Retention

$3.5M $3.0M $2.0M $1.0M $0 $1.1M 2022 Cohort 112% NRR $2.4M 2023 Cohort 138% NRR $3.2M 2024 Cohort 141% NRR* *Month 12, current trajectory

Unit Economics

Metric Value
CAC $14,200
LTV $210,600
LTV:CAC Ratio 14.8x
Payback Period 11 months
Gross Margin 76%

Customer Portfolio

Sunrise Pharmacy Group
14 locations
$238K ARR
MedFirst Partners
22 locations
$374K ARR
Valley Care Rx
9 locations
$153K ARR
Hometown Health Rx
6 locations
$102K ARR
Community Care Network
11 locations
$187K ARR
Premier Pharmacy Alliance
8 locations
$136K ARR
Beacon Rx Group
5 locations
$85K ARR
Central Pharmacy Partners
7 locations
$119K ARR
Cornerstone Health Rx
4 locations
$68K ARR
Green border = reference-willing accounts

Legacy Players

PioneerRx, BestRx
• Desktop-installed software
• Per-location pricing model
• No billing automation module
• No patient engagement layer
• 2-week on-site implementation

Arca

Cloud-native platform
• Per-chain pricing (incentive-aligned)
• Full module stack (POS → billing → loyalty)
• 18-month integration dataset moat
• Zero-churn once billing goes live
• Remote setup, 72-hour go-live

Market Expansion Path

Module Depth (1 module → full stack) Chain Size (small → mid-market) Today: Arca owns 2-8 location chains 2025-26 Expansion 10-30 location chains TAM: $1.4B

Product Roadmap

Funded by existing ARR, not this round. Customer co-development accelerates adoption.
Q4 2024
Rx Compounding Tracker
Automated workflow for sterile & non-sterile compounding. 3 pilot customers committed.
Q1 2025
Staff Scheduling AI
Predictive scheduling based on Rx volume patterns. Reduces labor cost 12-18%.
Q2 2025
Chain Analytics Dashboard
Cross-location performance benchmarking. First enterprise-grade analytics for independent chains.

The Team

Priya Menon
CEO & Co-Founder
8 years McKesson pharmacy operations. Stanford MBA. Built supplier network relationships that became Arca's distribution moat.
Derek Ault
CTO & Co-Founder
Ex-Veeva enterprise SaaS architect. 3 previous exits. Built billing automation engine that drove 67% module-2 attach rate.
Caroline Reyes
VP Sales
Built SMB motion at Mindbody from 0→$40M ARR. Owns $14K CAC and 11-month payback through conference-first strategy.
Jonah Kim
VP Customer Success
Zendesk CS leadership. Architected the QBR framework that delivers 138% NRR. Zero churn once billing module goes live.

ARR Growth Trajectory

Annual Recurring Revenue, 2022–2026

$25M $20M $10M $5M $0 2022 2023 2024 2025 2026 $800K $2.2M $5.1M $11.4M $24M post-round plan
Current Monthly Burn
$310K
Runway Pre-Raise
14 months

Use of Funds

35%
Product
4 engineers + 2 ML specialists
Build modules 4-6 on roadmap
40%
Go-to-Market
6 AEs + 2 SDRs
Scale conference strategy to 12 shows/year
15%
Customer Success
3 CSMs to protect NRR
1:20 CSM:customer ratio target
10%
G&A
Finance + HR infrastructure
SOC2 compliance preparation
Total Headcount Growth
18 → 47
Anchor our $12M Series A
Post-money valuation: $58M
Close target: September 30, 2024
Current lead conversations
Threshold Ventures • Gradient Capital
Priya Menon, CEO
priya@arca.health • 312-555-0147